Sign up to save your podcasts
Or
Share Remdesivir and Dexamethasone for the Treatment of COVID-19
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Remdesivir and Dexamethasone for the Treatment of COVID-19
Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments.
Related Article(s):
Missed Opportunities on Emergency Remdesivir Use
View all episodes
By JAMA Network
4.3
106106 ratings
Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments.
Related Article(s):
Missed Opportunities on Emergency Remdesivir Use
More shows like Coronavirus (COVID-19) Q&A
View all
JAMA Clinical Reviews
496 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
JAMA Cardiology Author Interviews
8 Listeners
JAMA Dermatology Author Interviews
17 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Oncology Author Interviews
11 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
7 Listeners
JAMA Pediatrics Author Interviews
9 Listeners
JAMA Psychiatry Author Interviews
22 Listeners
JAMA Medical News
87 Listeners
JAMAevidence Care at the Close of Life
5 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
JAMAevidence Users' Guides to the Medical Literature
15 Listeners
JAMA Network Open Conversations
5 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
21 Listeners
JAMA Health Forum Conversations
3 Listeners
JAMA Author Interviews
162 Listeners